製药自动化市场规模、份额和成长分析（按给药类型、自动化方法、最终用户、应用和地区划分）—2026-2033年产业预测

预计到 2024 年，全球製药自动化市场规模将达到 83.8 亿美元，到 2025 年将达到 92.9 亿美元，到 2033 年将达到 210.9 亿美元，预测期（2026-2033 年）的复合年增长率为 10.8%。

全球药房自动化产业正经历着变革性的转变，这主要得益于分析技术和软体的进步。这些创新显着提高了零售药局的营运效率和盈利，实现了惊人的十倍提升。自动化不仅最大限度地减少了药物浪费，还降低了单次用药成本，简化了药师的工作流程，同时提高了病患满意度。随着处方药和非处方药价格的持续上涨，自动化为製药公司提供了一条在不影响品质或安全性的前提下维持和扩大生产的途径。其他优势还包括更高的生产弹性和更快的生产线建设速度。弹性自动化、数位化、大量生产和个人化等当前产业趋势正在蓬勃发展，进一步巩固了自动化在当今製药业中的关键作用。

推动全球製药自动化市场发展的因素

全球製药自动化市场的成长受多种关键因素驱动，其中包括机器人技术在製药生产中日益普及。政府鼓励产业发展的扶持政策也进一步推动了这个趋势。此外，旨在提升效率和生产力的传统生产设施升级改造投资显着增加。加之消费者对安全、数位化生产流程的需求不断增长，这些因素共同促进了製药自动化的扩张，凸显了该行业向更先进、更自动化解决方案的转变。

限制全球製药自动化市场的因素

新冠疫苗生产的巨大需求，以及物联网技术在製药生产中日益广泛的应用，预计将为全球製药自动化市场创造巨大的成长机会。这些因素将推动创新，提升营运效率，使企业能够更好地适应不断变化的产业需求。随着自动化在维持生产流程的品质和速度方面变得愈发重要，市场有望受益于技术进步，从而提高整体生产效率和应对力市场波动的能力，最终形成更加激烈的竞争格局。

全球製药自动化市场趋势

受对先进技术日益增长的需求推动，药房自动化市场正经历显着增长，这些技术旨在最大限度地减少用药错误并提高营运效率。随着医疗系统努力提升患者安全并简化流程，自动化配药系统、机器人和整合软体解决方案的应用正在蓬勃发展。药品生产和分销的日益复杂化以及对监管合规性的日益重视进一步推动了这一趋势。此外，人工智慧 (AI) 和机器学习的整合有望变革传统做法，并为建立更有效率、更可靠的药品供应链铺平道路。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管环境

全球製药自动化市场规模（以交付方式划分）及复合年增长率（2026-2033 年）

• 硬体
• 软体
• 服务

全球製药自动化市场规模（按自动化方式和复合年增长率划分）（2026-2033 年）

• 全自动系统
• 半自动系统

全球製药自动化市场规模（按最终用户和复合年增长率划分）（2026-2033 年）

• 製药公司
• 研究所
• 契约製造组织（CMO）
• 受託研究机构（CRO）

全球製药自动化市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 药物发现
• 药物研发
• 临床试验
• 製造业
• 包装
• 品管

全球製药自动化市场规模（按地区划分）及复合年增长率（2026-2033 年）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Becton, Dickinson and Company（USA）
• Baxter International Inc.（USA）
• Siemens Healthineers（Germany）
• GE Healthcare（USA）
• Omnicell, Inc.（USA）
• Swisslog Healthcare（Switzerland）
• Capsa Healthcare（USA）
• Parata Systems（USA）
• ARxIUM（Canada）
• ScriptPro LLC（USA）
• Yuyama Co., Ltd.（Japan）
• McKesson Corporation（USA）
• Pearson Medical Technologies（USA）
• Accu-Chart Plus Healthcare Systems（USA）
• NewIcon（Finland）
• AlixaRx（USA）
• KUKA AG（Germany）
• TOSHO Inc.（Japan）
• Cerner Corporation（USA）

结论与建议

Global Pharmaceutical Automation Market size was valued at USD 8.38 Billion in 2024 and is poised to grow from USD 9.29 Billion in 2025 to USD 21.09 Billion by 2033, growing at a CAGR of 10.8% during the forecast period (2026-2033).

The global pharmaceutical automation landscape is experiencing a transformative shift, primarily driven by advancements in analytics and software. This innovation is dramatically enhancing operational efficiency and profitability within retail pharmacies, achieving an impressive tenfold improvement. Automation not only minimizes medication waste but also decreases per-dose costs, all while streamlining workflow for pharmacists and elevating patient satisfaction. As the prices of prescription and over-the-counter medications continue to rise, automation offers pharmaceutical companies a pathway to sustain or boost production without compromising quality or safety. Additionally, the sector benefits from increased production agility and rapid assembly of production lines. Current industry trends such as flexible automation, digitalization, batch production, and personalization have gained momentum, reinforcing the vital role of automation in today's pharmaceutical landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Automation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Automation Market Segments Analysis

Global Pharmaceutical Automation Market is segmented by Offering, Mode of Automation, End User, Application and region. Based on Offering, the market is segmented into Hardware, Software and Services. Based on Mode of Automation, the market is segmented into Fully-Automated Systems and Semi-Automated Systems. Based on End User, the market is segmented into Pharmaceutical Companies, Research Laboratories, Contract Manufacturing Organizations (CMOs) and Contract Research Organizations (CROs). Based on Application, the market is segmented into Drug Discovery, Drug Development, Clinical Trials, Manufacturing, Packaging and Quality Control. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceutical Automation Market

The growth of the Global Pharmaceutical Automation market is driven by several key factors, including the increasing integration of robotics in pharmaceutical manufacturing. Supportive government initiatives aimed at fostering industrial advancement further bolster this trend. Additionally, there is a notable surge in investments focused on upgrading conventional production facilities to enhance efficiency and productivity. Coupled with a growing consumer demand for safe and digitized manufacturing processes, these elements collectively contribute to the expanding landscape of pharmaceutical automation, highlighting a shift towards more advanced and automated solutions within the industry.

Restraints in the Global Pharmaceutical Automation Market

The significant demand for COVID-19 vaccine production, coupled with the increasing integration of IoT technology in pharmaceutical manufacturing, is expected to create considerable opportunities for growth within the Global Pharmaceutical Automation market. These factors are likely to drive innovation and enhance operational efficiency, allowing companies to adapt to evolving industry needs. As automation becomes more essential for maintaining quality and speed in production processes, the market is poised to benefit from advancements in technology that improve overall productivity and responsiveness to market fluctuations, ultimately facilitating a stronger competitive landscape.

Market Trends of the Global Pharmaceutical Automation Market

The global pharmaceutical automation market is experiencing significant growth driven by an increasing demand for advanced technologies that minimize medication errors and enhance operational efficiency. As healthcare systems seek to improve patient safety and streamline processes, the adoption of automated dispensing systems, robotics, and integrated software solutions is surging. This trend is further bolstered by the rising complexity of pharmaceutical manufacturing and distribution, alongside the growing emphasis on regulatory compliance. Additionally, the integration of artificial intelligence and machine learning is set to transform traditional practices, paving the way for a more efficient and reliable pharmaceutical supply chain.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Pharmaceutical Automation Market Size by Offering & CAGR (2026-2033)

• Market Overview
• Hardware
• Software
• Services

Global Pharmaceutical Automation Market Size by Mode of Automation & CAGR (2026-2033)

• Market Overview
• Fully-Automated Systems
• Semi-Automated Systems

Global Pharmaceutical Automation Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical Companies
• Research Laboratories
• Contract Manufacturing Organizations (CMOs)
• Contract Research Organizations (CROs)

Global Pharmaceutical Automation Market Size by Application & CAGR (2026-2033)

• Market Overview
• Drug Discovery
• Drug Development
• Clinical Trials
• Manufacturing
• Packaging
• Quality Control

Global Pharmaceutical Automation Market Size & CAGR (2026-2033)

• North America (Offering, Mode of Automation, End User, Application)
  • US
  • Canada
• Europe (Offering, Mode of Automation, End User, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Offering, Mode of Automation, End User, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Offering, Mode of Automation, End User, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Offering, Mode of Automation, End User, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omnicell, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Swisslog Healthcare (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Capsa Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parata Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARxIUM (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScriptPro LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Yuyama Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pearson Medical Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accu-Chart Plus Healthcare Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NewIcon (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AlixaRx (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KUKA AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TOSHO Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerner Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations